Vanessa Iribarrem Avena Miranda1, Antônio Augusto Schäfer2, Cristiane Damiani Tomasi2, Jacks Soratto3, Fernanda de Oliveira Meller2, Marysabel Pinto Telis Silveira4. 1. Postgraduate Program in Public Health, University of Southern Santa Catarina, Av. Universitária, 1105, Criciúma, Santa Catarina, CEP: 88806-000, Brazil. vanessairi@unesc.net. 2. Postgraduate Program in Public Health, University of Southern Santa Catarina, Av. Universitária, 1105, Criciúma, Santa Catarina, CEP: 88806-000, Brazil. 3. Postgraduate Program in Public Health, University of Southern Santa Catarina, Criciúma, Santa Catarina, Brazil. 4. Postgraduate Program in Epidemiology, University Federal of Pelotas, Pelotas, Rio Grande do Sul, Brazil.
Abstract
BACKGROUND: To guarantee prevention and adequate treatment, as required for the population to have access to health services and technologies, including medicines. The purpose of this study is to analyse the economic and regional inequalities in access to medicines for diabetes and hypertension among the adult population in Brazil. METHODS: This was a cross-sectional study with adults aged 18 and over from the VIGITEL study conducted in 2019 in all Brazilian regions. Non-access to antidiabetic and antihypertensive drugs was assessed according to formal education and housing macro-region. The slope index of inequality (SII) was used to analyse absolute inequalities. RESULTS: The total number of individuals interviewed was 52,443. Approximately 10.0% of the people with diabetes and/or hypertension reported not having access to drug treatment. The major means for having access to antihypertensive drugs, in all regions, was private pharmacies; for antidiabetics, in the North region, people had greater access through private pharmacies, while in the Northeast, Southeast and South, they had greater access through the public sector. Inequalities were found in the lack of access to medicines according to the region of residence, especially in the North region. CONCLUSION: The lack of access to medicines showed regional disparities, particularly in the most economically vulnerable regions.
BACKGROUND: To guarantee prevention and adequate treatment, as required for the population to have access to health services and technologies, including medicines. The purpose of this study is to analyse the economic and regional inequalities in access to medicines for diabetes and hypertension among the adult population in Brazil. METHODS: This was a cross-sectional study with adults aged 18 and over from the VIGITEL study conducted in 2019 in all Brazilian regions. Non-access to antidiabetic and antihypertensive drugs was assessed according to formal education and housing macro-region. The slope index of inequality (SII) was used to analyse absolute inequalities. RESULTS: The total number of individuals interviewed was 52,443. Approximately 10.0% of the people with diabetes and/or hypertension reported not having access to drug treatment. The major means for having access to antihypertensive drugs, in all regions, was private pharmacies; for antidiabetics, in the North region, people had greater access through private pharmacies, while in the Northeast, Southeast and South, they had greater access through the public sector. Inequalities were found in the lack of access to medicines according to the region of residence, especially in the North region. CONCLUSION: The lack of access to medicines showed regional disparities, particularly in the most economically vulnerable regions.
Entities:
Keywords:
Cross-sectional studies; Diabetes; Health inequalities; Hypertension; Pharmaceutical services; Pharmacoepidemiology
Authors: Paulo Sérgio Dourado Arrais; Luciara Leite Brito; Maurício Lima Barreto; Helena Lutéscia L Coelho Journal: Cad Saude Publica Date: 2006-01-09 Impact factor: 1.632
Authors: Maria Inês Schmidt; Bruce Bartholow Duncan; Gulnar Azevedo e Silva; Ana Maria Menezes; Carlos Augusto Monteiro; Sandhi Maria Barreto; Dora Chor; Paulo Rossi Menezes Journal: Lancet Date: 2011-05-09 Impact factor: 79.321
Authors: Deborah Carvalho Malta; Silvânia Suely Caribé de Araújo Andrade; Taís Porto Oliveira; Lenildo de Moura; Rogério Ruscitto do Prado; Maria de Fátima Marinho de Souza Journal: Rev Bras Epidemiol Date: 2019-04-01